Is Genomic Risk Stratification useful for Patients with early HR+/ERBB2 Breast Cancer?

被引：0
|
作者：
Lichert, Frank
机构：
来源：
GEBURTSHILFE UND FRAUENHEILKUNDE | 2023年 / 83卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：474 / 474
页数：1
相关论文
共 50 条
  • [21] Evaluation of agents targeting ErbB2 in breast cancer
    Kuruppu, A.
    Zhang, L.
    Thomas, N.
    Bradshaw, T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S209 - S209
  • [22] Treatment of ErbB2 breast cancer by mitochondrial targeting
    Sophia Eldad
    Rachel Hertz
    Gilad Vainer
    Ann Saada
    Jacob Bar-Tana
    Cancer & Metabolism, 8
  • [23] Treatment of ErbB2 breast cancer by mitochondrial targeting
    Eldad, Sophia
    Hertz, Rachel
    Vainer, Gilad
    Saada, Ann
    Bar-Tana, Jacob
    CANCER & METABOLISM, 2020, 8 (01)
  • [24] Flotillins as regulators of ErbB2 levels in breast cancer
    S Pust
    T I Klokk
    N Musa
    M Jenstad
    B Risberg
    B Erikstein
    L Tcatchoff
    K Liestøl
    H E Danielsen
    B van Deurs
    K Sandvig
    Oncogene, 2013, 32 : 3443 - 3451
  • [25] ERBB2 (HER2) Testing in Breast Cancer
    Hilal, Talal
    Romond, Edward H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (12): : 1280 - 1281
  • [26] ErbB2 immune response in breast cancer patients with soluble receptor ectodomain
    Visco, V
    Bei, R
    Moriconi, E
    Gianni, W
    Kraus, MH
    Muraro, R
    AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04): : 1417 - 1424
  • [27] Ribociclib in HR+/HER2-Advanced or Metastatic Breast Cancer Patients
    Rascon, Kaitlin
    Flajc, Goran
    De Angelis, Carmine
    Liu, Xinli
    Trivedi, Meghana V.
    Ekinci, Ekim
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (05) : 501 - 509
  • [28] Predictive value of multigene assay for chemotherapy benefit in patients with HR+/HER2-early breast cancer
    Kwon, Mi Jeong
    CANCER RESEARCH, 2018, 78 (13)
  • [29] Health-Related Quality of Life Among Patients With HR+/HER2-Early Breast Cancer
    Criscitiello, Carmen
    Spurden, Dean
    Piercy, James
    Rider, Alex
    Williams, Rhys
    Mitra, Debanjali
    Wild, Rosie
    Corsaro, Massimo
    Kurosky, Samantha K.
    Law, Ernest H.
    CLINICAL THERAPEUTICS, 2021, 43 (07) : 1228 - +
  • [30] Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2- Early Breast Cancer
    Ni, Hua
    Kumbrink, Joerg
    Mayr, Doris
    Seiler, Alina
    Hagemann, Friederike
    Degenhardt, Tom
    Sagebiel, Sabine
    Wuerstlein, Rachel
    Kates, Ronald
    Harbeck, Nadia
    Eggersmann, Tanja K.
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (09):
12345